Avastin just as good as lucentis
Links shared publicly online about this topic.
- 1,355total visits
Avastin just as good as lucentis
View full resource at eyedocnews.com
Tags: Colorectal Cancer Medication, Avastin
Most Recently Shared on February 25, 2010 at 10:39 pm By:
Discuss: Avastin Just As Good As Lucentis: By Dr. Ari WeitznerDuh! Everybody knows this “secretâ€. A new study in O... http://bit.ly/cCyk68
Here's the knowledge for tomorrow's CMS MEDCAC meeting on Lucentis and Avastin in DME: http://t.co/3MLUVvfA. Good times all around.
t.co — “Here's the knowledge for tomorrow's CMS MEDCAC meeting on Lucentis and Avastin in DME: http://t.co/3MLUVvfA. Good times all around.” View full resource at t.co
Most Recently Shared on March 20, 2012 at 4:01 pm By:
Ramsey Baghdadi Health Communicator
Here's the knowledge for tomorrow's CMS MEDCAC meeting on Lucentis and Avastin in DME: http://t.co/3MLUVvfA. Good times all around.
Eylea Treatment for Wet Macular Degeneration
retinaeyedoctor.com — “Eylea is a new FDA approved treatment for the wet macular degeneration. The novel drug will require fewer injections compared to Lucentis or Avastin.” View full resource at retinaeyedoctor.com
Most Recently Shared on December 6, 2011 at 3:17 pm By:
Randall Wong, MD Physician, Doctor, Surgeon, and Ophthalmologist
Eylea As Good As Lucentis http://t.co/591fRbuA
Could Novartis’ Earnings Be Good For Regeneron? - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “Is there room for another eye drug that works much like the already available medicines Lucentis and Avastin, both made by Roche? Tarrytown, NY-based Regeneron and its partner, Bayer, are betting there is. The pair's drug, Eylea, has a dosing advantage compared to Lucentis. But the big question is whether there [...]” View full resource at blogs.forbes.com
Most Recently Shared on July 19, 2011 at 1:22 pm By:
Drugs and Devices OW OW Health
Could Novartis' Earnings Be Good For Regeneron?: One analyst argues that the performance of Novartis' L... http://onforb.es/qPoCNT #drug
Avastin and Lucentis Are Equally Safe, Too. http://goo.gl/fb/xvvOf
retinaeyedoctor.com — “Safety data from the second year of the CATT study were just released at ARVO. Both drugs equally safe with regard to death and stroke.” View full resource at retinaeyedoctor.com
Most Recently Shared on May 10, 2011 at 3:43 pm By:
Randall Wong, MD Physician, Doctor, Surgeon, and Ophthalmologist
Avastin and Lucentis Are Equally Safe, Too. http://goo.gl/fb/xvvOf
Avastin Just as Good as Lucentis http://goo.gl/fb/tFz9P
retinaeyedoctor.com — “CATT study data indicates that Avastin injections for wet macular degeneration are equally effective as Lucentis. Both are safe.” View full resource at retinaeyedoctor.com
Most Recently Shared on May 4, 2011 at 2:25 pm By:
Randall Wong, MD Physician, Doctor, Surgeon, and Ophthalmologist
Avastin Just as Good as Lucentis http://goo.gl/fb/tFz9P
Avastin as Good as Lucentis for AMD Treatment
webmd.com — “$50 worth of Avastin prevents blindness from age-related macular degeneration (AMD), and does it just as well as $2,000 worth of Lucentis, a federally funded clinical trial finds.” View full resource at webmd.com
Most Recently Shared on April 29, 2011 at 9:46 pm By:
Avastin as Good as Lucentis for AMD Treatment: $50 worth of Avastin prevents blindness from age-related macular ... http://bit.ly/lkTUY0
Clinical Trial Says Avastin as Effective as Lucentis for Macular Degeneration - NYTimes.com
nytimes.com — “The trial said that Avastin is just as effective at treating a form of macular degeneration as the more expensive Lucentis.” View full resource at nytimes.com
Most Recently Shared on April 29, 2011 at 5:30 pm By:
Effectiveness doesn't always mean higher costs RT @nytimeshealth: Cheaper Drug to Treat Eye Disease Is Effective http://ow.ly/4JGGf
Avastin Proves As Good As Pricier Lucentis for Eye Disease Wet Macular Degeneration - Drugs.com MedNews
drugs.com — “From Canadian Press DataFile (April 28, 2011) A much cheaper drug has proved just as good as a 2,000 monthly shot to treat a common eye disorder that can lead t” View full resource at drugs.com
Most Recently Shared on April 29, 2011 at 3:06 pm By:
Drugs and Devices OW OW Health
Avastin Proves As Good As Pricier Lucentis for Eye Disease Wet Macular Degeneration: From Canadian Press D... http://bit.ly/lm3mXE #drug
Avastin: Drug compares to Lucentis in treating age-related macular degeneration - latimes.com
latimes.com — “Avastin and the more expensive Lucentis are equally effective, suggests early clinical trial results, but Avastin might have more side effects” View full resource at latimes.com
Most Recently Shared on April 28, 2011 at 10:17 pm By:
LA Times Health News Health News
Avastin just as effective as Lucentis in treating macular degeneration, study finds http://lat.ms/kcz3eb
Cheaper Roche drug as good as Lucentis: report - Yahoo! News
news.yahoo.com — “Avastin, a cancer drug made by Roche Holding AG, was about as effective as the company's far more expensive eye drug, Lucentis, at preventing vision loss in people with age-related macular degeneration, the New York Times reported on Wednesday.” View full resource at news.yahoo.com
Most Recently Shared on April 28, 2011 at 7:27 pm By:
Cheaper Roche drug as good as Lucentis: report (Reuters) http://yhoo.it/lA4aDb
Avastin, Lucentis Perform Nearly Equally Despite Cost Difference, Study Shows - ABC News
abcnews.go.com — “One drug costs $50 per dose. The other costs $2,000 per dose. Now, new research shows that the drug Avastin, normally used in cancer treatment, is just about as effective at treating an eye disease that can lead to blindness as the more commonly used and more expensive Lucentis.” View full resource at abcnews.go.com
Most Recently Shared on April 28, 2011 at 6:32 pm By:
HealthIT Policy Health News and Health IT
Cheap Eye Drug Just as Good as Pricier One: One drug costs $50 per dose. The other costs $2,000 per dose. Now, n... http://bit.ly/jDyntw
Head-to-head eye drug results confirmed for May 1 | Reuters
reuters.com — “* Lucentis vs Avastin study to feature at ARVO congress * Data may appear in journal simultaneously or earlier * Lucentis at risk if far cheaper Avastin proves as good LONDON, April 20 (Reuters)” View full resource at reuters.com
Most Recently Shared on April 20, 2011 at 6:46 pm By:
John Carroll Health Communicator
Lucentis vs. Avastin data due out May 1. Also significant for Regeneron program. http://reut.rs/fAEMvy
Head-to-head eye drug results tipped for early May | Reuters
reuters.com — “* Lucentis vs Avastin study may feature at May 1-5 congress * Lucentis at risk if far cheaper Avastin proves as good * Lucentis brings in $1.5 bln/yr for both Roche and Novartis By Ben Hirschler” View full resource at reuters.com
Most Recently Shared on March 30, 2011 at 2:20 pm By:
Ben Hirschler Health Communicator
Waiting for the head-to-head Lucentis vs Avastin CATT trial results? Watch out at ARVO meeting, May 1-5 http://t.co/6RHP4v5 #Novartis #Roche
Health Business Blog » Blog Archive » Why you shouldn’t feel good about paying a low price for wet AMD treatment
healthbusinessblog.com — “Health Business Blog » Blog Archive » Why you shouldn’t feel good about paying a low price for wet AMD treatment” View full resource at healthbusinessblog.com
Most Recently Shared on March 4, 2011 at 11:08 pm By:
David Williams Health Executive
Why you should feel bad about paying a low price for wet AMD treatment. Avastin v. Lucentis http://bit.ly/dEkzom #in
Former UCSF postdoc wins 2010 Lasker Award for work on angiogenesis, Avastin, LUCENTIS - UCSF Today
today.ucsf.edu — “Genentech scientist Napoleone Ferrara, who has just been named the winner of a Lasker Award, is being recognized for his noteworthy achievements made when he was a postdoc at UCSF.” View full resource at today.ucsf.edu
Most Recently Shared on September 24, 2010 at 7:27 pm By:
Ferrera’s Lasker Award-Winning Research Began at UCSF http://bit.ly/cbk4m8 #lasker
Advertisement
